Atrevia® Trio Cats Spot On Small

Atrevia® Trio Cats Spot On Small

Multi-Action Topical Ecto-endoparasite with 12 Weeks of Protection

Felines Topical Solution

Fluralaner 112.50 mg, moxidectin 5.60 mg, praziquantel 36.00 mg, excipients q.s.ad 0.40 mL.

For the treatment and control of mixed infestations caused by endoparasites and ectoparasites in cats, whenever concomitant action is required against ticks (Ixodes ricinus, Ixodes holocyclus, Ixodes hexagonus, Rhipicephalus sanguineus and Dermacentor reticulatus), fleas (Ctenocephalides felis), mites of skin (Demodex gatoi, Demodex cati, Lynxacarus radovskyi and Notoedres cati) and ear (Otodectes cynotis), gastrointestinal nematodes (Toxocara cati, Toxocara malaysiensis, Ancylostoma tubaeforme, Ancylostoma braziliense, Ancylostoma ceylanicum, Uncinaria stenocephala, Toxascaris leonina, Trichuris campanula and Trichuris serrata) and lungworms (Aelurostrongylus abstrusus, Troglostrongylus brevior and Eucoleus aerophilus), heartworm larvae (Dirofilaria immitis) and cestodes (Dipylidium caninum, Taenia taeniaeformis). The action against ectoparasites lasts 12 weeks. When administered repeatedly at 12-week intervals, it continuously prevents heartworm disease caused by Dirofilaria immitis (heartworm)

Topically, at the rate of 1 pipette for cats between 1.2 and 2.8 kg live weight, every 12 weeks.
Box x 1 Pipette, Box x 5 Pipettes.

SENASA Registry: F.009.037.N.00479

This content is informative reference and should not be considered as prescriptions.

You may also be interested

Agrogenta® 11
Agrogenta® 11
Broad-spectrum aminoglycoside
Injectable Solution
Hematofos B12®
Hematofos B12®
Multi-tonic complemented with phosphorous
Injectable Solution
Vetonic® con Nucleótidos
Vetonic® con Nucleótidos
Integral biostimulant, growth promoter. Unique with nucleotides
Oral Solution